The Impact of Infectious Disease on QT Segment

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02960256

Enrollment

169

Registered

2016-11-09

Start date

2016-12-31

Completion date

2017-03-31

Last updated

2018-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiomyopathy, Secondary, Pneumonia, Sepsis

Brief summary

Sepsis related to the development of cardiac complications. However, the investigators understanding regarding this condition remains incomplete. Possible explanations raised include coronary perfusion decrease, activation of the coagulation system and release of inflammatory mediators, including endotoxins, cytokines and others. In this study the investigators wanted to examine the impact of any infectious disease, (not necessarily Pneumonia), on the QT interval in patients hospitalized for acute infectious disease.

Interventions

DEVICEekocardiogram test

ekocardiogram test

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 120 Years

Healthy volunteers

Inclusion criteria

* Internal ward hospitalized patient, due to illness which its etiology is bacterial, fungal or viral

Exclusion criteria

* Can not technically perform reliably ECG (amputated legs, lack of cooperation, etc.) * Subject with permanent pacemaker

Design outcomes

Primary

Measure	Time frame	Description
Prolongation of the QT	5 days	QT will be measured by ECG

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026